Activism

Supreme Court to Decide Fate of Cross-State Abortion Access

Emily Davis
Senior Reporter
Updated
Dec 14, 2024 8:12 PM
News Image

The conflict surrounding abortion access intensifies as Texas Attorney General Ken Paxton files a lawsuit against Dr. Megan Carpenter for purportedly sending abortion pills to a resident of Texas. The lawsuit addresses Carpenter’s actions while also questioning the efficacy of New York’s shield law, which aims to safeguard abortion providers from legal repercussions originating from other states.

The case revolves around two medications, mifepristone and misoprostol, which are utilized safely in early-term abortions. Texas contends that Carpenter breached its laws by prescribing the pills through telemedicine without holding a Texas medical license. Paxton is pursuing fines amounting to $100,000 for each violation and an injunction to stop similar practices.

Carpenter can utilize New York’s shield law to initiate a counter-suit, alleging unlawful interference with protected rights. Legal scholar Mary Ziegler observes that a resolution might eventually necessitate a ruling from the Supreme Court.

This legal dispute underscores the broader difficulties faced by abortion providers as they maneuver through a complex array of state regulations. From April to June 2024, shield laws enabled more than 9,700 medication abortions in states with strict rules, highlighting their essential function in maintaining access following the Roe decision.

New York Attorney General Letitia James pledged to support Carpenter, characterizing the lawsuit as a means to intimidate abortion providers. "We will stand strong against any threats," she affirmed.

CTA Image
CTA Image
CTA Image
CTA Image
CTA Image
CTA Image
CTA Image
CTA Image
CTA Image
CTA Image
CTA Image
CTA Image
CTA Image
CTA Image
CTA Image
CTA Image

Access exclusive content and analysis.

From breaking news to thought-provoking opinion pieces, our newsletter keeps you informed and engaged with what matters most. Subscribe today and join our community of readers staying ahead of the curve.